# AMOXICILLIN AND CLAVULANATE POTASSIUM
> **ANDA217805** · Abbreviated New Drug Application (Generic) · Sponsor: MICRO LABS · Approved 2023-12-08
## Drug
- **FDA Application Number:** ANDA217805
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** AMOXICILLIN AND CLAVULANATE POTASSIUM
- **Generic name:** AMOXICILLIN AND CLAVULANATE POTASSIUM
- **Active ingredients:** AMOXICILLIN; CLAVULANATE POTASSIUM
- **Dosage form:** FOR SUSPENSION
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** MICRO LABS
- **Manufacturer:** Micro Labs Limited
- **First approval:** 2023-12-08
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217805)
---
*AI Analytics · CC0 1.0*